Sarepta Therapeutics
SRPT
SRPT
269 hedge funds and large institutions have $4.2B invested in Sarepta Therapeutics in 2018 Q1 according to their latest regulatory filings, with 53 funds opening new positions, 76 increasing their positions, 110 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
6% more funds holding
Funds holding: 254 → 269 (+15)
1.9% more ownership
Funds ownership: 85.46% → 87.36% (+1.9%)
31% less repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 110
Holders
269
Holding in Top 10
6
Calls
$198M
Puts
$111M
Top Buyers
| 1 | +$310M | |
| 2 | +$113M | |
| 3 | +$51M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$38.2M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$34.1M |
Top Sellers
| 1 | -$72.9M | |
| 2 | -$64.5M | |
| 3 | -$64.3M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$35.8M |
| 5 |
Millennium Management
New York
|
-$33.4M |